Xeris Pharmaceuticals
XERS
#4025
Rank
A$4.56 B
Marketcap
A$24.97
Share price
-2.18%
Change (1 day)
128.57%
Change (1 year)

Earnings for Xeris Pharmaceuticals (XERS)

Earnings in 2026 (TTM): A$17.39 Million

According to Xeris Pharmaceuticals's latest financial reports the company's current earnings are A$0.33 Billion. In 2025 the company made an earning of A$44.52 Million, an increase over its 2024 earnings that were of -A$40 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Xeris Pharmaceuticals from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$17.39 M-60.94%
2025 A$44.52 M-211.34%
2024 -A$40 Million-27.85%
2023 -A$55.44 Million-54.31%
2022 -A$0.13 Billion-30.11%
2021 -A$0.18 Billion43.37%
2020 -A$0.13 Billion-32.21%
2019 -A$0.18 Billion106.61%
2018 -A$86.45 Million116.69%
2017 -A$39.9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.24 Billion-1,508.29%๐Ÿ‡บ๐Ÿ‡ธ USA